Year: 2024

– Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate clinically meaningful activity in 2L+ HNSCC – Conference call on Saturday, Dec. 7 at 9:00 a.m. ET to discuss full data set UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 01, 2024 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the publication of an abstract regarding petosemtamab, a Biclonics® targeting EGFR and LGR5, in previously treated (2L+) patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC) on the European Society for Medical Oncology (ESMO®) Asia Congress website. The abstract presents updated clinical data on petosemtamab from the...

Philips CT 5300 with AI-enabled workflowClinical image of the heart with Precise Cardiac on Philips CT 5300December 1, 2024Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and interventional imaging accessible to more patients, including reading support with Automated AI-enabled Philips Advanced Visualization Workspace applications Philips collaborates with Annalise.ai to evaluate streamlining workflows to prioritize time-sensitive casesAmsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a boost in confidence in clinical decision-support with AI and smart workflow automation capabilities in the company’s recently introduced CT 5300 system, which is making...

philips-next-gen-blueseal-mri-2ct-5300-product-image-2next-gen-blueseal-mri-with-smart-readingDecember 1, 2024 Philips’ intelligent diagnostic and treatment solutions, combined with its advanced capabilities in healthcare informatics, uniquely position the company to drive precision imaging for a greater number of patients Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled the company’s latest AI-powered diagnostic and treatment imaging innovations to advance precise imaging with faster, easier and more efficient workflows. Addressing key challenges faced by radiologists, these innovations are complemented by Philips’ industry-leading expertise in cloud-based data management, advanced visualization, automation, and AI....

RICHMOND, Va., Dec. 01, 2024 (GLOBE NEWSWIRE) — Today GPM Investments, LLC launched the MDA Holiday Retail Campaign in support of Muscular Dystrophy Association’s (MDA) mission at approximately 1,500 locations across the United States from December 1 through December 31, 2024. For more than 13 years GPM Investments has raised funds to accelerate research, advance care, and advocate to empower families living with muscular dystrophy, ALS, and related neuromuscular diseases. We invite customers to participate in the MDA Holiday retail campaign by purchasing a $1 or $5 pinup or rounding up their purchase. Donations made by customers will be displayed on special MDA Holiday pinups in each location, showing support for MDA families. Donations to this year’s holiday campaign may also be made directly online here.  Today GPM Investments,...

DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control system for image interpretation to ensure AI scalability, performance monitoring, and safety, with the aim to accelerate the adoption of AI. DeepHealth currently monitors the performance of DeepHealth’s SmartMammo™ AI-powered solution for breast cancer detection at RadNet. Through the collaboration, the two companies aim to expand, productize and scale this control system across more applications to other customers.Furthermore, DeepHealth will embed CARPL.ai’s cutting-edge AI orchestration capabilities that enable easy selection, implementation, and monitoring of appropriate AI models within DeepHealth’s cloud-native operating system, DeepHealth OS.LOS ANGELES and SOMERVILLE, Mass., Dec. 01, 2024 (GLOBE...

20,575 vehicles were delivered in November 2024, increasing by 28.9% year-over-year 190,832 vehicles were delivered year-to-date in 2024, increasing by 34.4% year-over-year Cumulative deliveries reached 640,426 as of November 30, 2024  SHANGHAI, Dec. 01, 2024 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced its November 2024 delivery results. The Company delivered 20,575 vehicles in November 2024, representing an increase of 28.9% year-over-year. The deliveries consisted of 15,493 vehicles from the Company’s premium smart electric vehicle brand NIO, and 5,082 vehicles from the Company’s family-oriented smart electric vehicle brand ONVO. Cumulative deliveries reached 640,426 as of November 30, 2024. November...

30,895 units delivered in November, up 54% year-over-year MONA M03 surpassed 10,000 deliveries for third consecutive month P7+ launch drives strong delivery momentumGUANGZHOU, China, Dec. 01, 2024 (GLOBE NEWSWIRE) — XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announced record-breaking vehicle delivery results for November 2024. XPENG delivered 30,895 Smart EVs in November 2024, representing growth of 54% year-over-year and 29% over the prior month. Deliveries of XPENG MONA M03 exceeded 10,000 units for the third consecutive month since its launch. After 23 days of launch, deliveries of XPENG P7+ exceeded 7,000 units. For the first eleven months of 2024, XPENG delivered 153,373 Smart EVs, a 26% increase from the same period last year. In...

AUSTIN, Texas, Dec. 01, 2024 (GLOBE NEWSWIRE) — Mondee Holdings, Inc. (Nasdaq: MOND) (“Mondee” or the “Company”), a leading travel marketplace and artificial intelligence (AI) technology company, announced today that the Company received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) issuing a Staff determination (the “Staff Determination”) on November 27, 2024 after the Company informed the Staff that it would not contest a delisting of its Common Stock. The Staff Determination noted that based on Staff’s review and the Form 8-K filed on November 26, 2024 (the “Form 8-K”), they have determined to delist the Company’s securities from The Nasdaq Stock Market. The Form 8-K stated that, “On November 25, 2024, the Company’s Board of Directors (the “Board”) determined that...

SARASOTA, Fla., Nov. 30, 2024 (GLOBE NEWSWIRE) — Trump Media & Technology Group (Nasdaq: DJT) (“TMTG”) CEO Devin Nunes today issued the following statement following President-elect Trump’s announcement of his intent to nominate TMTG board member Kash Patel as Director of the FBI: “An immensely talented lawyer and investigator with an unimpeachable devotion to our Constitution, Kash is a brilliant pick to serve as Director of the FBI. Kash and I worked closely together to expose the saboteurs within the Intelligence Community who perpetuated the Russia collusion hoax. Based on that experience, along with his service in key positions in the first Trump Administration, I know Kash has the intelligence and fearlessness to expose the corruption in the FBI, reverse its damaging politicization, and restore Americans’...

BEIJING, China, Dec. 01, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it delivered 48,740 vehicles in November 2024, up 18.8% year over year. As of November 30, 2024, Li Auto had delivered a total of 441,995 vehicles in 2024, with cumulative deliveries reaching 1,075,359. Li Auto maintained its best-selling position among Chinese automotive brands in the RMB200,000 and above passenger vehicle market for eight straight months. Li L6 achieved over 160,000 cumulative deliveries, retaining as the sales champion among Chinese brand models priced above RMB200,000 since June. Additionally, the Company’s continuous advancements in autonomous driving technologies have boosted demand for models equipped with Li AD Max. In November,...